-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care
Sign up for news updates
Mary Jo Fidler
-
Patient, Provider Safety Paramount During Pandemic: Telehealth Benefits Are Numerous
By Mary Jo Fidler, MD Posted: June 10, 2020 Healthcare systems in the United States have been slow to adopt telehealth, in part, due to regulatory limitations, patient privacy concerns, and less reimbursement potential.1 However, at the same time, there has been an enormous effort to incorporate electronic health records (EHR) driven by programs…
-
Telehealth Successes and Challenges
Posted: June 9, 2020 Across specialties, COVID-19 has resulted in increased patient anxiety and decreased in-person appointments. The rapid uptake of telehealth has, for some, widened disparity gaps and been an obstacle in maintaining patient–physician relationships; for others, telehealth has presented an opportunity to provide consistent long-term care to patients in the safety and comfort…
View ILCN Archives
Provider Resources
Popular Articles